American Century Companies’s Recursion Pharmaceuticals RXRX Stock Holding History

American Century Companies's RXRX Position: Q1 2026 in Review

American Century Companies increased its Recursion Pharmaceuticals (RXRX) stake by 28% in Q1 2026, buying an estimated $265K and bringing the position to 310,434 shares worth $953K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

American Century Companies first reported a position in RXRX in Q3 2021 and has held it in 10 quarters since. The position peaked at $5.19M in Q4 2021. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

• American Century Companies held 310,434 shares of Recursion Pharmaceuticals worth $953K as of Q1 2026.
• American Century Companies bought 68,469 Recursion Pharmaceuticals shares in Q1 2026, an estimated $265K.
• Recursion Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2343 holding.
• American Century Companies first reported a position in Recursion Pharmaceuticals in Q3 2021 and has held it in 10 quarters since.
• American Century Companies's Recursion Pharmaceuticals position peaked at $5.19M in Q4 2021.
• 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.